Clinical Trial Update: Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Evuzamitide in transthyretin amyloidosis used PET/CT to measure potential therapeutic response; the study has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis

Drugs mentioned

• Evuzamitide

Snippet

Sponsor: Columbia University | Conditions: Transthyretin Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-18